|
Aug 08, 2024 |
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
|
PDF
|
|
Aug 05, 2024 |
Oncocyte Announces August Investor Conferences Participation
|
PDF
|
|
Aug 01, 2024 |
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
|
PDF
|
|
Jun 17, 2024 |
Oncocyte Appoints Andrea James as Chief Financial Officer
|
PDF
|
|
May 30, 2024 |
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
|
PDF
|
|
May 15, 2024 |
Oncocyte Reports First Quarter 2024 Financial Results
|
PDF
|
|
May 13, 2024 |
Oncocyte to Announce First Quarter 2024 Financial Results
|
PDF
|
|
Apr 12, 2024 |
Oncocyte Reports Full Year 2023 Financial Results
|
PDF
|
|
Apr 11, 2024 |
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
|
PDF
|
|
Apr 11, 2024 |
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
|
PDF
|
